Latest News about IMMP
Recent news which mentions IMMP
From Benzinga
 
   Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo
   
  
  
  May 15, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 
   Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
   
  
  
  November 14, 2024
  From Benzinga
 
   Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
   
  
  
  September 16, 2024
  From Benzinga
 
   Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
   
  
  
  July 29, 2024
  From Benzinga
 
   Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
   
  
  
  July 12, 2024
  From Benzinga
 From InvestorPlace
 From Benzinga
 From Benzinga
 From Benzinga
 From InvestorPlace
 
   12 Health Care Stocks Moving In Wednesday's Intraday Session
   
  
  
  April 24, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why
   
  
  
  March 05, 2024
  From Benzinga
 
   7 Stocks That Could Triple Your Money by 2024
   
  
  
  August 09, 2023
  From InvestorPlace
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
   
  
  
  August 03, 2023
  From Benzinga
 
   3 Best Penny Stocks Under $3 to Buy in June
   
  
  
  June 14, 2023
  From InvestorPlace
 
   Immutep Touts Encouraging Data From Efti Triple Combination Therapy In Lung Cancer Setting
   
  May 24, 2023
  Tickers 
   IMMP
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From InvestorPlace
 
   7 Best Penny Stocks Under $3 to Buy in April
   
  
  
  April 12, 2023
  From InvestorPlace
 From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


